Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

A New Score Predicting Survival Prognosis After Whole-Brain Radiotherapy Alone for Brain Metastases in Elderly Patients

JASMIN N. EVERS, STEVEN E. SCHILD, BARBARA SEGEDIN, VIORICA NAGY, MAI TRONG KHOA, NGO THUY TRANG and DIRK RADES
Anticancer Research May 2014, 34 (5) 2455-2458;
JASMIN N. EVERS
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEVEN E. SCHILD
2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BARBARA SEGEDIN
3Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIORICA NAGY
4Department of Radiotherapy, Oncology Institute Ion Ciricuta, Cluj-Napoca, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAI TRONG KHOA
5Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
6Department of Nuclear Medicine, Hanoi Medical University, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NGO THUY TRANG
5Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Rades.Dirk@gmx.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 5 2455-2458
PubMed 
24778060

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 27, 2014
  • Revision received March 20, 2014
  • Accepted March 21, 2014
  • Published online April 28, 2014.

Copyright & Usage 
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. JASMIN N. EVERS1,
  2. STEVEN E. SCHILD2,
  3. BARBARA SEGEDIN3,
  4. VIORICA NAGY4,
  5. MAI TRONG KHOA5,6,
  6. NGO THUY TRANG5 and
  7. DIRK RADES1⇑
  1. 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  2. 2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  3. 3Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
  4. 4Department of Radiotherapy, Oncology Institute Ion Ciricuta, Cluj-Napoca, Romania
  5. 5Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
  6. 6Department of Nuclear Medicine, Hanoi Medical University, Hanoi, Vietnam
  1. Correspondence to: Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany. Tel: +49 4515006661, Fax: +49 4515003324, e-mail: Rades.Dirk{at}gmx.net
View Full Text

Statistics from Altmetric.com

Cited By...

  • 22 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 34 (5)
Anticancer Research
Vol. 34, Issue 5
May 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A New Score Predicting Survival Prognosis After Whole-Brain Radiotherapy Alone for Brain Metastases in Elderly Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 18 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A New Score Predicting Survival Prognosis After Whole-Brain Radiotherapy Alone for Brain Metastases in Elderly Patients
JASMIN N. EVERS, STEVEN E. SCHILD, BARBARA SEGEDIN, VIORICA NAGY, MAI TRONG KHOA, NGO THUY TRANG, DIRK RADES
Anticancer Research May 2014, 34 (5) 2455-2458;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A New Score Predicting Survival Prognosis After Whole-Brain Radiotherapy Alone for Brain Metastases in Elderly Patients
JASMIN N. EVERS, STEVEN E. SCHILD, BARBARA SEGEDIN, VIORICA NAGY, MAI TRONG KHOA, NGO THUY TRANG, DIRK RADES
Anticancer Research May 2014, 34 (5) 2455-2458;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Distress Scores in Elderly Cancer Patients During Radiotherapy
  • Short Communication: Results of a Consensus Conference on Radiotherapy for Brain and Bone Metastases Within the Interreg-Project TreaT
  • A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy
  • Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly
  • Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer
  • Evaluation of Five Survival Scores in a Cohort of Elderly Patients With Cerebral Metastasis from Non-small Cell Lung Cancer
  • The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer
  • Extra-cerebral Metastasis - An Independent Predictor of Survival in Older Patients With Brain Metastases Receiving a Local Therapy Plus Whole-Brain Radiotherapy (WBRT)
  • Remaining Lifespan of Patients Aged >=65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary
  • An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer
  • Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer
  • A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation
  • A Tool to Estimate Survival of Elderly Patients Presenting with Metastatic Epidural Spinal Cord Compression (MESCC) from Cancer of Unknown Primary
  • Metastatic Spinal Cord Compression: A Survival Score Particularly Developed for Elderly Prostate Cancer Patients
  • Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients
  • Survival After Palliative Radiotherapy in Geriatric Cancer Patients
  • Google Scholar

More in this TOC Section

  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
Show more Clinical Studies

Similar Articles

Keywords

  • brain metastasis
  • elderly patients
  • whole-brain radiotherapy
  • prognostic factors
  • survival
  • score
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire